AstraZeneca, Juno latest to collaborate on immuno-oncology drugs
April 23, 2015 at 10:24 AM EDT
April 23 (Reuters) - A unit of AstraZeneca Plc has teamed up with Juno Therapeutics Inc to develop combination treatments that use the body's immune system to kill cancer cells.
